首页> 美国卫生研究院文献>European Heart Journal >Treating hypertension in the very elderly—benefits risks and future directions a focus on the hypertension in the very elderly trial
【2h】

Treating hypertension in the very elderly—benefits risks and future directions a focus on the hypertension in the very elderly trial

机译:在老年人中治疗高血压的益处风险和未来方向重点是老年人试验中的高血压

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although the number of individuals reaching 80 who are considered to be healthy is increasing, the very elderly are likely to have long-term conditions, to report symptoms and/or be taking at least one regular medication. The impact of antihypertensive treatment has to be taken into account in this context. The treatment regimen in Hypertension in the Very Elderly Trial with a goal blood pressure of <150/80 mmHg has been shown to provide benefits in terms of a reduction in risk of total mortality, stroke, and cardiovascular events with potential benefits and no evidence of increased risk for fracture, dementia, depression, and quality-of-life outcomes. Questions remain as to the level of benefit that would be accrued in the frailer elderly and those at extreme age, for example, over 90.
机译:尽管达到80岁的被认为是健康的人的数量正在增加,但是非常年老的人可能会长期处于病态,报告症状和/或正在服用至少一种常规药物。在这种情况下,必须考虑降压治疗的影响。在目标为<150/80 mmHg的目标血压的老年试验中,高血压的治疗方案已被证明可以降低总死亡率,中风和心血管事件的风险,并且具有潜在的益处,并且没有证据表明骨折,痴呆,抑郁和生活质量转归的风险增加。对于年老体弱的人和90岁以上的极端年龄的人所能获得的福利水平仍然存在疑问。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号